Additional file 3: of Challenges and opportunities associated with the introduction of next-generation long-lasting insecticidal nets for malaria control: a case study from Burkina Faso

Supplementary Quotes. (DOCX 115 kb

Additional file 1 of Healthcare provider and drug dispenser knowledge and adherence to guidelines for the case management of malaria in pregnancy in the context of multiple first-line artemisinin-based combination therapy in western Kenya

Additional file 1. The Strengthening the reporting of observational studies in epidemiology (STROBE) checklist

Analysis framework for focus group discussions with trial participants.

<p>Analysis framework for focus group discussions with trial participants.</p

Factors influencing reduced effectiveness of intermediate processes in the delivery of IPTp-SP, IPTp-SP by DOT and ITNs (in the presence of required stock).

<p>Notes:</p><p>SP, Sulfadoxine-pyrimethamine; ITN, Insecticide Treated Net; CSCom, Community health center; CSRef, Reference health center; ANC, Antenatal Clinic; DOT, Direct Observed Treatment; IPTp, Intermittent Preventive Treatment; SES, Socio-economic Status; CFA, Franc XOF;</p><p>↑, arrow indicating high level; ↓, arrow indicating low level.</p

Healthcare provider practices: diagnosis.

∧<p>Equal numbers used clinical and laboratory tests.</p>§<p>Multiple response answers.</p>€<p>Lower cadre providers (senior and junior community health extension workers and pharmacy technicians).</p>α<p>Higher cadre providers (doctors, nurses, and community health officers).</p>†<p>Used clinical and lab-based tests: 62% sometimes and 26% always.</p>µ<p>25.6% used both RDT and microscopy.</p>¢<p>Used RDTs only.</p>¥<p>Policy document identified by review authors.</p>∞<p>Frequency of RDT use: always 9.2%, most of time 33.6%, sometimes 22.7%, rarely 26.1%, never 8.4%.</p>±<p>Microscopy or RDT; 3% used clinical and lab.</p>≠<p>Healthcare provider asks about presence of fever/assesses for signs and symptoms of anaemia.</p><p>CHW, community health worker; DV, drug vendor/shop; HP, healthcare provider; MA, medical assistant; MD, medical doctor; NA, not reported by study authors; pharm, pharmacist (trained); PSI, Population Services International Research and Metrics; PW, pregnant women.</p

Data on the determinants of treatment-seeking behaviours for malaria in pregnancy by pregnant women.

<p>All effects measured using the Chi-squared test.</p><p>SES, socio-economic status.</p

Prevalence of adherence to treatment policy for malaria in pregnancy assessed in 15 studies with quantitative data.

<p>Pf, <i>P. falciparum</i>; Pv, <i>P. vivax</i>; self-administered, self-administered questionnaire; MiP, malaria in pregnancy.</p

Analysis strategy.

<p>Analysis strategy.</p

Integration of findings in relation to WHO case management policy [1].

<p>LBW, low birth weight.</p

Factors reducing the effectiveness for pregnant women of receiving any IPTp-SP by DOT when of eligible gestation during an ANC visit.

<p>Note: SP, sulfadoxine-pyrimethamine; ANC, antenatal clinic; DOT, directly observed treatment; IPTp, intermittent preventive treatment.</p